Feb. 21, 2017
1:00-2:00 p.m. ET
Rare diseases affect an estimated 25 million Americans. On Tuesday, Feb. 21, 2017, 1:00-2:00 p.m. ET, NIH will host a Twitter Chat on rare diseases. The chat will feature NIH Director Francis Collins, M.D., Ph.D., NCATS Director Christopher P. Austin, M.D., NCATS Office of Rare Diseases Research Director Petra Kaufmann, M.D., M.Sc. and many others. Join the conversation by following #NIHChat.
Feb. 27, 2017
8:30 a.m.-4:00 p.m. ET
Masur Auditorium, Building 10
NIH Clinical Center
Sponsored by NCATS and the NIH Clinical Center, Rare Disease Day at NIH will take place from 8:30 a.m. to 4:00 p.m. in Masur Auditorium, Building 10 on the NIH main campus in Bethesda. Confirmed NIH speakers include NCATS Director Christopher P. Austin, M.D., NCATS Office of Rare Diseases Research and Division of Clinical Innovation Director Petra Kaufmann, M.D., M.Sc., and Anthony Fauci, M.D., director, National Institute of Allergy and Infectious Diseases. Some additional speakers include Rep. Leonard Lance (R-NJ), co-chair, Rare Disease Congressional Caucus; Margaret Anderson, M.S., executive director, FasterCures; Max Bronstein, senior director for advocacy and science policy at EveryLife Foundation for Rare Diseases; Sharon Terry, M.A., president and CEO, Genetic Alliance; Scott Shirley, executive director, Uplifting Athletes; and Wendy White, chairman of the Board of Directors for Global Genes®. View the agenda for a complete list of participating speakers.
The event will feature presentations, posters, exhibits, tours of the NIH Clinical Center and an art show. Admission is free and open to the public. In association with Global Genes, participants are encouraged to wear their favorite pair of jeans. Be sure to follow the event on social media using #RDDNIH.
March 9-12, 2017
Fairmont Copley Plaza
138 St. James Ave.
Boston, Massachusetts 02116
This Keystone Symposia meeting will highlight rapidly emerging cell-based tools for fundamental and applied discovery. Speakers will discuss culture systems, ranging from simple cell cluster organoids to highly advanced, cell-electronic composites. In addition, they will highlight the encouraging progress underway in cell-based therapies across a range of organs and diseases. The goal of this meeting is to provide a state-of-the-art review of both pluripotent and differentiated cells as tools for discovery and therapy.
NCATS Director Christopher P. Austin, M.D., will deliver the welcome and keynote address, Catalyzing Translational Innovation, on Friday, March 10, 2017, at 8:30 a.m. ET.
May 4, 2017
8:30 a.m.-5:30 p.m. ET
National Institutes of Health
Building 31C, 6th Floor, Conference Room 6
The NCATS Advisory Council and Cures Acceleration Network (CAN) Review Board will convene a joint meeting in open session on Thursday, May 4, 2017, at 8:30 a.m. ET. The meeting will feature presentations from NCATS Director Christopher P. Austin, M.D., and others about the Center’s initiatives, policies, programs and future direction. For more information about the Advisory Council and CAN Review Board, visit the NCATS Advisory Council page and the Cures Acceleration Network Review Board page of this site.